ArticleFrontiers in immunology2025

Signal mining and analysis of influencing factors for adverse events of Nivolumab and Cetuximab in the treatment of head and neck cancer based on the US FAERS database.

Yi Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.